Healthcare Business Investment Opportunities

Tech-enabled B2B pharmaceutical distribution platform, focusing on simplifying pharmacy procurement from over 50 distributors. - 2,000+ pharmacies served till date. - Revenue model: 8-10% EBITDA margin on B2B sales, projected to grow. - Promoters: Founder (Forbes 30 under 30 Asia, IIT Bombay, Y-Combinator) and Co-Founder (25 years pharma distribution experience). - Backed by Bluewatch Ventures, Soma Capital, Enrission India Capital, and Goodwater. - $4.2M seed funding raised (3 years ago). - 150+ pharma brands integrated. - Business has a registration and distribution license.

The company is a retailer of medical devices and diagnostic systems. - Its top-selling products include hospital beds and MRI scanning devices. - The business serves 15 government hospitals in Zambia and sources products from dealers in China, Korea, and Australia. - Approximately 80% of revenue comes from medical equipment retail, while the remaining 20% is generated through the company acting as a building contractor for specific projects. - We have 3 permanent employees who ensure smooth operations. - The owner is based in Australia and can be contacted directly through the provided number.

The company is a retailer of medical devices and diagnostic systems. - Its top-selling products include hospital beds and MRI scanning devices. - The business serves 15 government hospitals in Zambia and sources products from dealers in China, Korea, and Australia. - Approximately 80% of revenue comes from medical equipment retail, while the remaining 20% is generated through the company acting as a building contractor for specific projects. - We have 3 permanent employees who ensure smooth operations. - The owner is based in Australia and can be contacted directly through the provided number.

Our venture operates a dual-channel revenue model through Shopify D2C and EU-based pharmacy/retail B2B, supported by a 3PL logistics hub in Brno. We serve an expanding base of early adopters across Europe and New Zealand, with a projected year-1 capacity to scale to 15,000 customers through digital acquisition and pharmacy distribution. We operate on a fully compliant, asset-light supply chain model, with the following foundations already in place: EU compliance completed (CPSR/CPNP) Responsible Person (RP) structure established. Unique New Zealand ingredient IP. GMP-certified contract manufacturing partners. Active market preparation and channel development. D2C Shopify and pharmacy/retail B2B distribution. Founder expertise: 20+ years in procurement, supply chain, GMP/ISO implementation, and corporate governance, supported by a Master’s in Business Administration. Our partnerships with award-winning R&D labs enable end-to-end NPD within a high-quality and premium standard production framework. The new product development process has been constrained by the partner’s abrupt withdrawal of funds. Manufacturing & fulfilment: All production is via GMP-certified contract manufacturers. Storage, pick/pack, and fulfilment managed by a 3PL warehouse in Brno, including climate-controlled storage and EU-wide distribution. Highly scalable setup enabling rapid expansion across EU markets without physical infrastructure investment. Scale & clients: 18 active B2B partners across New Zealand, the Czech Republic, and the Netherlands. 5 contract manufacturers (GMP / ISO 22716 certified). Initial B2C launch targeting 5,000–7,000 consumers in the first 12 months through the Shopify Plus EU hub. Revenue model: 70% B2B ingredient supply to EU formulators and private-label brands. 30% B2C sales via e-commerce of clean-label, daily effervescent collagen + antioxidant products. Promoter experience: 20+ years in procurement, manufacturing, and international trade. Prior leadership in supply-chain optimisation and product commercialisation across NZ, EU, and CIS markets. We work with contractors who are specialists in the EU legal framework and with a pharmaceutical-certified facility under the supervision of skilled staff to increase our earnings. Both branches operate under the same legal entity.

Operates a pharmaceutical manufacturing unit in Nalagarh, Baddi with WHO-GMP, GLP and ISO certifications. - Produces tablets, capsules, liquid orals, ointments and a CEFA dry powder injection line for government supply, domestic buyers and export clients. - Facility is designed as a general section layout with controlled environments for multiple dosage forms. - Current handling capacity is around 1000 cartons across product categories. - Holds Food and Drug licenses along with active registration on the MCA portal. - Positioned to serve institutional orders and private-label requirements with compliant processes and quality documentation. - Experienced team manages regulatory, technical and quality operations with a focus on international standards. - The business faced legal issues five years ago related to the manufacturing of COVID vaccines. Since then, the charges have been dropped, and it is now legally clear to operate.

Operates a medicine wholesale business supplying pharmaceutical products to local vendors and small retailers. - Serves a steady customer base of around 146 buyers with recurring procurement needs. - Procures medicines from major brands and distributes them directly to local vendors at competitive rates. - Functions as a reliable link in the supply chain for fast-moving pharmaceutical items and essential healthcare products. - Holds a valid GST certification and is registered with the MCA, ensuring compliant operations.

Located in Central Hong Kong, the clinic specializes in advanced health treatments, focusing primarily on IV drips, Ozempic, and blood tests. - IV drips are the top-selling product, accounting for 70% of the clinic's revenue, catering to customers seeking hydration and nutrient therapy. - Ozempic, a medication used for weight management and diabetes control, represents 20% of sales, appealing to patients looking for effective health solutions. - Blood tests contribute to 10% of the clinic's sales, providing essential diagnostics for preventive health care and monitoring various medical conditions. - The clinic attracts approximately 100-200 customers per month, establishing a loyal customer base in the competitive healthcare market. - With strong sales and profitability, the clinic effectively meets the growing demand for outpatient health services in Hong Kong. - Utilizing innovative treatments and a customer-centric approach, the clinic positions itself as a leading health provider in the region, maximizing revenue through high-demand services. - Holds and operates with a valid clinic license.

• Pre-revenue digital venture launching two platforms under one company: an edtech learning platform and an authorised beauty-product reselling platform. • Platform 1 delivers digital-marketing training programs for MSME owners, entrepreneurs, and students seeking practical skills to grow their businesses or build expertise. • Platform 2 resells beauty products sourced from authorised vendors of leading brands such as Nivea and Lotus; discussions with suppliers are in the finalisation stage. • Both platforms are already built and operational, positioned for immediate commercial rollout. • Initial combined revenue is projected at INR 5 lakh per month (INR 3 lakh from edtech and INR 2 lakh from beauty products). • Operating cost estimated at INR 2 lakh per month, with a projected profit of INR 3 lakh once revenue stabilises. • Promoter brings 8+ years of experience as an investment banker and advisor to multiple startups. • Holds Udyam registration and is seeking capital to scale both platforms simultaneously.

• Contract manufacturing business specializing in beauty and personal care products such as moisturisers, lipsticks, and hair care items. • Contract manufacturing contributes 85% of revenue, serving 5–10 regular customers across domestic and export markets. • Also sells products under its own brand with established export operations. • Large-scale manufacturing capacity capable of producing INR 4–5 crore worth of products per day; currently operating at low utilisation. • This year has seen a rise in orders and sales, and hence, the run-rate sales have significantly increased. However, our focus is on scaling volume rather than optimising margins, and we are focusing on further expansion. • Promoter has 40 years of industry experience and represents the fourth generation in the family business. • Holds GST, MSME, FSSAI, and IEC registrations, ensuring full compliance for domestic and international distribution. • Well positioned for rapid growth through increased capacity utilization and expanded export partnerships.

Community-focused herbal medical shop in Khilkhet, Dhaka, specialized in natural and herbal products, addressing health needs with a unique approach. - Offers a wide range of products including herbal medicines, Ayurvedic items, beauty products, and basic health supplies to promote holistic well-being. - Provides home delivery services, making it convenient for customers, especially those in rural areas, to access affordable healthcare solutions. - Conducts health consultations to educate customers on the benefits of natural remedies, enhancing overall customer trust and loyalty. - Targets a diverse customer base, with a focus on individuals with long-term illnesses, skin problems, gastric issues, hormonal concerns, and general health needs. - Generates an average monthly sales of 1,60,000 BDT with a net profit of approximately 50,000 BDT per month, showcasing strong financial stability. - Supports local families by offering affordable healthcare solutions and aims to create a sustainable income source for the owner’s family through community-centered efforts. - Holds a valid trade license, ensuring compliance with local regulations and enhancing business credibility in the pharmaceutical sector.

Upcoming chain of quaternary-care hospitals designed to deliver advanced multi-organ transplant services, robotic surgeries and ECMO support. - Founded by promoters with over twenty years of experience in tertiary and quaternary healthcare operations. - Led by a team of senior doctors as directors, each with established practice bases and strong patient trust. - Target population covers more than seven districts with high awareness and affordability, creating strong demand potential. - Addresses a significant gap in bed availability in Coimbatore, positioning the project as a viable and timely healthcare model. - Phase one includes a 250 bed quaternary care hospital supported by peripheral centres. - Phase two plans to add 300 additional quaternary beds along with 500 secondary care beds across tier three cities. - Focused on building a multi-location healthcare ecosystem offering advanced treatments close to underserved populations. - Final registrations and compliance processes are underway and expected to be completed within the next one year. - The land has been acquired, and the construction, design, and layout of the hospital building are finalized. The final construction work will begin in January next year, with the building expected to be functional by the end of the year.